Guy Lallement

Title: Guy Lallement: Innovator in Neurotoxicology

Introduction

Guy Lallement is a notable inventor based in Seyssins, France. He has made significant contributions to the field of neurotoxicology, particularly through his innovative patents. With a total of 2 patents, Lallement's work focuses on therapeutic applications that aim to mitigate the effects of neurotoxic substances in warm-blooded animals.

Latest Patents

Lallement's latest patents include groundbreaking methods for inhibiting the effects of neurotoxic products. One patent describes a method involving the therapeutic use of a thienylcyclohexylamine derivative. This method comprises administering an effective amount of a reversible cholinesterase inhibitor, such as pyridostigmine or physostigmine, to warm-blooded animals before exposure to neurotoxic products. The second patent outlines a similar therapeutic application, focusing on the administration of 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane to inhibit the effects of neurotropic products.

Career Highlights

Guy Lallement is associated with the company Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.). His work has been instrumental in advancing therapeutic methods that protect warm-blooded animals from neurotoxic effects. His innovative approaches have garnered attention in the scientific community.

Collaborations

Lallement has collaborated with notable coworkers, including Pierre Bernard D'Arbigny and Jean-Marc Kamenka. These collaborations have contributed to the development of his patents and the advancement of research in neurotoxicology.

Conclusion

Guy Lallement's contributions to the field of neurotoxicology through his innovative patents demonstrate his commitment to advancing therapeutic methods. His work continues to have a significant impact on the protection of warm-blooded animals from neurotoxic substances.